Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents

As a part of our project pointed at the search of new safe chemotherapeutic and chemoprophylactic agents against parasitic diseases, several compounds structurally related to 4-phenoxyphenoxyethyl thiocyanate (WC-9), which were modified at the terminal aromatic ring, were designed, synthesized and e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Szajnman, Sergio Hernán, Moreno, Silvia N. J., Rodríguez, Juan Bautista
Publicado: 2013
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02235234_v69_n_p480_Elicio
http://hdl.handle.net/20.500.12110/paper_02235234_v69_n_p480_Elicio
Aporte de:
id paper:paper_02235234_v69_n_p480_Elicio
record_format dspace
spelling paper:paper_02235234_v69_n_p480_Elicio2025-07-30T18:00:07Z Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents Szajnman, Sergio Hernán Moreno, Silvia N. J. Rodríguez, Juan Bautista Antiparasitic agents Chagas disease Squalene synthase inhibitors Toxoplasma gondii WC-9 analogs Toxoplasmosis Trypanosoma cruzi 3 (4 methoxyphenoxy)phenoxyethyl thiocyanate 3 phenoxyphenoxyethyl thiocyanate 4 (3 methoxyphenoxy)phenoxyethyl thiocyanate 4 (3 nitrophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether 4 (3 nitrophenoxy)phenoxyethyl thiocyanate 4 (4 methoxyphenoxy)phenoxyethyl thiocyanate 4 (pyridin 3 yloxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether 4 (pyridin 3 yloxy)phenoxyethyl thiocyanate 4 phenoxyphenoxyethyl thiocyanate antiparasitic agent atovaquone benznidazole nitro derivative thiocyanic acid derivative unclassified drug antiproliferative activity article biological activity Chagas disease controlled study drug cytotoxicity drug design drug screening drug synthesis nonhuman tachyzoite Toxoplasma gondii toxoplasmosis Trypanosoma cruzi Antiparasitic agents Chagas disease Squalene synthase inhibitors Toxoplasma gondii Toxoplasmosis Trypanosoma cruzi WC-9 analogs Antiparasitic Agents Dose-Response Relationship, Drug Drug Design Molecular Structure Parasitic Sensitivity Tests Phenyl Ethers Structure-Activity Relationship Thiocyanates Toxoplasma Trypanosoma cruzi As a part of our project pointed at the search of new safe chemotherapeutic and chemoprophylactic agents against parasitic diseases, several compounds structurally related to 4-phenoxyphenoxyethyl thiocyanate (WC-9), which were modified at the terminal aromatic ring, were designed, synthesized and evaluated as antiproliferative agents against Trypanosoma cruzi, the parasite responsible of American trypanosomiasis (Chagas disease) and Toxoplasma gondii, the etiological agent of toxoplasmosis. Most of the synthetic analogs exhibited similar antiparasitic activity being slightly more potent than the reference compound WC-9. For example, the nitro derivative 13 showed an ED50 value of 5.2 μM. Interestingly, the regioisomer of WC-9, compound 36 showed similar inhibitory action than WC-9 indicating that para-phenyl substitution pattern is not necessarily required for biological activity. The biological evaluation against T. gondii was also very promising. The ED50 values corresponding for 13, 36 and 37 were at the very low micromolar level against tachyzoites of T. gondii. © 2013 Elsevier Masson SAS. All rights reserved. Fil:Szajnman, S.H. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Moreno, S.N.J. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Rodriguez, J.B. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2013 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02235234_v69_n_p480_Elicio http://hdl.handle.net/20.500.12110/paper_02235234_v69_n_p480_Elicio
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Antiparasitic agents
Chagas disease
Squalene synthase inhibitors
Toxoplasma gondii WC-9 analogs
Toxoplasmosis
Trypanosoma cruzi
3 (4 methoxyphenoxy)phenoxyethyl thiocyanate
3 phenoxyphenoxyethyl thiocyanate
4 (3 methoxyphenoxy)phenoxyethyl thiocyanate
4 (3 nitrophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (3 nitrophenoxy)phenoxyethyl thiocyanate
4 (4 methoxyphenoxy)phenoxyethyl thiocyanate
4 (pyridin 3 yloxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (pyridin 3 yloxy)phenoxyethyl thiocyanate
4 phenoxyphenoxyethyl thiocyanate
antiparasitic agent
atovaquone
benznidazole
nitro derivative
thiocyanic acid derivative
unclassified drug
antiproliferative activity
article
biological activity
Chagas disease
controlled study
drug cytotoxicity
drug design
drug screening
drug synthesis
nonhuman
tachyzoite
Toxoplasma gondii
toxoplasmosis
Trypanosoma cruzi
Antiparasitic agents
Chagas disease
Squalene synthase inhibitors
Toxoplasma gondii
Toxoplasmosis
Trypanosoma cruzi
WC-9 analogs
Antiparasitic Agents
Dose-Response Relationship, Drug
Drug Design
Molecular Structure
Parasitic Sensitivity Tests
Phenyl Ethers
Structure-Activity Relationship
Thiocyanates
Toxoplasma
Trypanosoma cruzi
spellingShingle Antiparasitic agents
Chagas disease
Squalene synthase inhibitors
Toxoplasma gondii WC-9 analogs
Toxoplasmosis
Trypanosoma cruzi
3 (4 methoxyphenoxy)phenoxyethyl thiocyanate
3 phenoxyphenoxyethyl thiocyanate
4 (3 methoxyphenoxy)phenoxyethyl thiocyanate
4 (3 nitrophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (3 nitrophenoxy)phenoxyethyl thiocyanate
4 (4 methoxyphenoxy)phenoxyethyl thiocyanate
4 (pyridin 3 yloxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (pyridin 3 yloxy)phenoxyethyl thiocyanate
4 phenoxyphenoxyethyl thiocyanate
antiparasitic agent
atovaquone
benznidazole
nitro derivative
thiocyanic acid derivative
unclassified drug
antiproliferative activity
article
biological activity
Chagas disease
controlled study
drug cytotoxicity
drug design
drug screening
drug synthesis
nonhuman
tachyzoite
Toxoplasma gondii
toxoplasmosis
Trypanosoma cruzi
Antiparasitic agents
Chagas disease
Squalene synthase inhibitors
Toxoplasma gondii
Toxoplasmosis
Trypanosoma cruzi
WC-9 analogs
Antiparasitic Agents
Dose-Response Relationship, Drug
Drug Design
Molecular Structure
Parasitic Sensitivity Tests
Phenyl Ethers
Structure-Activity Relationship
Thiocyanates
Toxoplasma
Trypanosoma cruzi
Szajnman, Sergio Hernán
Moreno, Silvia N. J.
Rodríguez, Juan Bautista
Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents
topic_facet Antiparasitic agents
Chagas disease
Squalene synthase inhibitors
Toxoplasma gondii WC-9 analogs
Toxoplasmosis
Trypanosoma cruzi
3 (4 methoxyphenoxy)phenoxyethyl thiocyanate
3 phenoxyphenoxyethyl thiocyanate
4 (3 methoxyphenoxy)phenoxyethyl thiocyanate
4 (3 nitrophenoxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (3 nitrophenoxy)phenoxyethyl thiocyanate
4 (4 methoxyphenoxy)phenoxyethyl thiocyanate
4 (pyridin 3 yloxy)phenoxyethyl tetrahydro 2h pyran 2 yl ether
4 (pyridin 3 yloxy)phenoxyethyl thiocyanate
4 phenoxyphenoxyethyl thiocyanate
antiparasitic agent
atovaquone
benznidazole
nitro derivative
thiocyanic acid derivative
unclassified drug
antiproliferative activity
article
biological activity
Chagas disease
controlled study
drug cytotoxicity
drug design
drug screening
drug synthesis
nonhuman
tachyzoite
Toxoplasma gondii
toxoplasmosis
Trypanosoma cruzi
Antiparasitic agents
Chagas disease
Squalene synthase inhibitors
Toxoplasma gondii
Toxoplasmosis
Trypanosoma cruzi
WC-9 analogs
Antiparasitic Agents
Dose-Response Relationship, Drug
Drug Design
Molecular Structure
Parasitic Sensitivity Tests
Phenyl Ethers
Structure-Activity Relationship
Thiocyanates
Toxoplasma
Trypanosoma cruzi
description As a part of our project pointed at the search of new safe chemotherapeutic and chemoprophylactic agents against parasitic diseases, several compounds structurally related to 4-phenoxyphenoxyethyl thiocyanate (WC-9), which were modified at the terminal aromatic ring, were designed, synthesized and evaluated as antiproliferative agents against Trypanosoma cruzi, the parasite responsible of American trypanosomiasis (Chagas disease) and Toxoplasma gondii, the etiological agent of toxoplasmosis. Most of the synthetic analogs exhibited similar antiparasitic activity being slightly more potent than the reference compound WC-9. For example, the nitro derivative 13 showed an ED50 value of 5.2 μM. Interestingly, the regioisomer of WC-9, compound 36 showed similar inhibitory action than WC-9 indicating that para-phenyl substitution pattern is not necessarily required for biological activity. The biological evaluation against T. gondii was also very promising. The ED50 values corresponding for 13, 36 and 37 were at the very low micromolar level against tachyzoites of T. gondii. © 2013 Elsevier Masson SAS. All rights reserved.
author Szajnman, Sergio Hernán
Moreno, Silvia N. J.
Rodríguez, Juan Bautista
author_facet Szajnman, Sergio Hernán
Moreno, Silvia N. J.
Rodríguez, Juan Bautista
author_sort Szajnman, Sergio Hernán
title Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents
title_short Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents
title_full Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents
title_fullStr Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents
title_full_unstemmed Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents
title_sort design, synthesis and biological evaluation of wc-9 analogs as antiparasitic agents
publishDate 2013
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02235234_v69_n_p480_Elicio
http://hdl.handle.net/20.500.12110/paper_02235234_v69_n_p480_Elicio
work_keys_str_mv AT szajnmansergiohernan designsynthesisandbiologicalevaluationofwc9analogsasantiparasiticagents
AT morenosilvianj designsynthesisandbiologicalevaluationofwc9analogsasantiparasiticagents
AT rodriguezjuanbautista designsynthesisandbiologicalevaluationofwc9analogsasantiparasiticagents
_version_ 1840325493843296256